![Pharmacologic Approaches to Glycemic Treatment of Type 2 Diabetes: Synopsis of the 2020 American Diabetes Association's Standards of Medical Care in Diabetes Clinical Guideline | Primary Care IPA Pharmacologic Approaches to Glycemic Treatment of Type 2 Diabetes: Synopsis of the 2020 American Diabetes Association's Standards of Medical Care in Diabetes Clinical Guideline | Primary Care IPA](https://primarycareipa.org/wp-content/uploads/2020/11/pt-chart1.38_1.jpg)
Pharmacologic Approaches to Glycemic Treatment of Type 2 Diabetes: Synopsis of the 2020 American Diabetes Association's Standards of Medical Care in Diabetes Clinical Guideline | Primary Care IPA
![Expanding access to newer medicines for people with type 2 diabetes in low-income and middle-income countries: a cost-effectiveness and price target analysis - The Lancet Diabetes & Endocrinology Expanding access to newer medicines for people with type 2 diabetes in low-income and middle-income countries: a cost-effectiveness and price target analysis - The Lancet Diabetes & Endocrinology](https://www.thelancet.com/cms/asset/b2c0fa87-783e-431b-9875-88b62f1d30c9/gr1.jpg)
Expanding access to newer medicines for people with type 2 diabetes in low-income and middle-income countries: a cost-effectiveness and price target analysis - The Lancet Diabetes & Endocrinology
![2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) | SpringerLink 2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00125-019-05039-w/MediaObjects/125_2019_5039_Fig2_HTML.png)
2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) | SpringerLink
![Use of glucose-lowering medications in the management of type 2 diabetes | Download Scientific Diagram Use of glucose-lowering medications in the management of type 2 diabetes | Download Scientific Diagram](https://www.researchgate.net/publication/363815108/figure/fig3/AS:11431281094298367@1667443753090/Use-of-glucose-lowering-medications-in-the-management-of-type-2-diabetes.png)
Use of glucose-lowering medications in the management of type 2 diabetes | Download Scientific Diagram
![Initiation and Titration of Basal Insulin in Primary Care: Barriers and Practical Solutions | American Board of Family Medicine Initiation and Titration of Basal Insulin in Primary Care: Barriers and Practical Solutions | American Board of Family Medicine](https://www.jabfm.org/content/jabfp/32/3/431/F1.large.jpg)
Initiation and Titration of Basal Insulin in Primary Care: Barriers and Practical Solutions | American Board of Family Medicine
![From glucose lowering agents to disease/diabetes modifying drugs: a “SIMPLE” approach for the treatment of type 2 diabetes | Cardiovascular Diabetology | Full Text From glucose lowering agents to disease/diabetes modifying drugs: a “SIMPLE” approach for the treatment of type 2 diabetes | Cardiovascular Diabetology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12933-021-01281-y/MediaObjects/12933_2021_1281_Fig3_HTML.png)
From glucose lowering agents to disease/diabetes modifying drugs: a “SIMPLE” approach for the treatment of type 2 diabetes | Cardiovascular Diabetology | Full Text
![Edgar V. Lerma 🇵🇭 on X: "Glucose lowering medications in Type 2 Diabetes: Established ASCVD or CKD #Nephpearls #Cardiorenal #AHA18 🇺🇸 👉🏼 https://t.co/E11n7xQkjL https://t.co/ZqqvqpZeWt" / X Edgar V. Lerma 🇵🇭 on X: "Glucose lowering medications in Type 2 Diabetes: Established ASCVD or CKD #Nephpearls #Cardiorenal #AHA18 🇺🇸 👉🏼 https://t.co/E11n7xQkjL https://t.co/ZqqvqpZeWt" / X](https://pbs.twimg.com/media/DrrCSHUXgAIxaCB.jpg:large)